Bennett debuts as unit of ThermoTrex
Bennett X-Ray will mark its first RSNA meeting as a subsidiaryof ThermoTrex Medical, the division formed in September afterLorad parent ThermoTrex Corp. bought Bennett, of Copiague, NY. Don't expect any major changes in Bennett's RSNA booth, as
Bennett X-Ray will mark its first RSNA meeting as a subsidiaryof ThermoTrex Medical, the division formed in September afterLorad parent ThermoTrex Corp. bought Bennett, of Copiague, NY.
Don't expect any major changes in Bennett's RSNA booth, as ThermoTrexplans to allow Lorad and Bennett to maintain their separate identitieswithin ThermoTrex Medical. The two firms will integrate some oftheir imaging technologies, however.
For example, Bennett is developing a line of radiographic equipmentto be sold through Lorad's sales channels. ThermoTrex said Bennett'sexpertise in radiography was a major factor in the company's acquisitionof Bennett. The Bennett systems will be shown in Lorad's boothand will carry the Lorad label.
Bennett has also made a name for itself in digital mammography,and the company will show its latest work in the area. The companywill debut one of its first full-view digital production units,as well as patient images acquired with the system.
In radiography, Bennett will unveil a trauma C-arm designed tobe mounted on a wall rather than a ceiling, in order to save space.The company will show a new line of R&F and fluoroscopic high-fieldgenerators, as well as a prone stereotactic breast biopsy tableto complement its upright stereotactic system.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
